TheProfitWatch

ABOS - Acumen Pharmaceuticals, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
2.34 -0.05 (-2.14%) --- --- --- 0.01 (0.31%) -0.06 (-2.55%) 0.0 (0.0%) 0.01 (0.31%)

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
-0.68
Diluted EPS:
-0.68
Basic P/E:
-3.3676
Diluted P/E:
-3.3676
RSI(14) 1m:
41.67
VWAP:
2.29
RVol:
0.5674

Events

Period Kind Movement Occurred At
1m Price decrease 1m 2.23 -0.02 (-1.08%) Oct 15 13:32
1m Price increase 1m 2.22 +0.03 (+1.14%) Oct 15 13:12
1m Price increase 1m 2.27 +0.07 (+3.15%) Oct 15 12:23
10m Price increase 10m 2.27 +0.07 (+3.15%) Oct 15 12:23
1m Price decrease 1m 2.23 -0.03 (-1.33%) Oct 15 10:44

Related News